The T-ALL patients with high CRLF2 expression exhibited a trend toward higher median WBC (82.0 × 109/L vs. 24.8 × 109/L, P = 0.256) than those with low CRLF2 expression. Here, CRLF2 is linked to acute lymphoblastic leukemia.